Cargando…

The Effect of Rosuvastatin in a Murine Model of Influenza A Infection

RATIONALE: HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory effects that may reduce the severity of influenza A infection. We hypothesized that rosuvastatin would decrease viral replication, attenuate lung injury, and improve mortality following influ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radigan, Kathryn A., Urich, Daniela, Misharin, Alexander V., Chiarella, Sergio E., Soberanes, Saul, Gonzalez, Angel, Perlman, Harris, Wunderink, Richard G., Budinger, G. R. Scott, Mutlu, Gökhan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335012/ https://www.ncbi.nlm.nih.gov/pubmed/22536437 http://dx.doi.org/10.1371/journal.pone.0035788

Ejemplares similares

Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages
por: Radigan, Kathryn A., et al.
Publicado: (2014)

Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice
por: Mutlu, Ece A, et al.
Publicado: (2011)

Alcohol Worsens Acute Lung Injury by Inhibiting Alveolar Sodium Transport through the Adenosine A1 Receptor
por: Dada, Laura, et al.
Publicado: (2012)

Particulate matter Air Pollution induces hypermethylation of the p16 promoter Via a mitochondrial ROS-JNK-DNMT1 pathway
por: Soberanes, Saul, et al.
Publicado: (2012)

Particulate Matter-Induced Lung Inflammation Increases Systemic Levels of PAI-1 and Activates Coagulation Through Distinct Mechanisms
por: Budinger, G. R. Scott, et al.
Publicado: (2011)

Modeling human influenza infection in the laboratory
por: Radigan, Kathryn A, et al.
Publicado: (2015)

The heterogeneity of lung macrophages in the susceptibility to disease
por: Morales-Nebreda, Luisa, et al.
Publicado: (2015)

Epidemic Viral Pneumonia and Other Emerging Pathogens
por: Radigan, Kathryn A., et al.
Publicado: (2011)

The application of qNMR for the determination of rosuvastatin in tablet form
por: DİKMEN, Gökhan, et al.
Publicado: (2021)

A Call for Rational Intensive Care in the Era of COVID-19
por: Singer, Benjamin D., et al.
Publicado: (2020)

Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner
por: Cuda, Carla M., et al.
Publicado: (2015)

Pharmacological inhibition of PAI-1 alleviates cardiopulmonary pathologies induced by exposure to air pollutants PM(2.5)()
por: Ghosh, Asish K., et al.
Publicado: (2021)

Influenza and bacterial pneumonia - constant companions
por: Wunderink, Richard G
Publicado: (2010)

Rosuvastatin treatment alone cannot alleviate lupus in murine model: a pilot study
por: Baek, Wook-Young, et al.
Publicado: (2023)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

PNEUMONIA | Overview and Epidemiology
por: Wunderink, R.G., et al.
Publicado: (2006)

Suppression of inflammation and acute lung injury by the transcription factor Miz1 via repression of C/EBP-δ
por: Do-Umehara, Hanh Chi, et al.
Publicado: (2013)

Development of a new humanized mouse model to study acute inflammatory arthritis
por: Misharin, Alexander V, et al.
Publicado: (2012)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Rosuvastatin induced photolocalized purpura
por: Thabouti, Marwa, et al.
Publicado: (2022)

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
por: Ren, Yizhi, et al.
Publicado: (2017)

Design, development, and characterization of amorphous rosuvastatin calcium tablets
por: González, Rocío, et al.
Publicado: (2022)

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
por: Tijeras-Raballand, Annemilaï, et al.
Publicado: (2010)

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
por: Wheaton, William W, et al.
Publicado: (2014)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

Preparation and optimization of microemulsion of rosuvastatin calcium
por: Patel, Zalak B., et al.
Publicado: (2012)

Rosuvastatin-Induced Acute Interstitial Nephritis
por: Londrino, Francesco, et al.
Publicado: (2013)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
por: Wang, Lijun, et al.
Publicado: (2018)

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)

Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
por: Saeedi, Ramesh, et al.
Publicado: (2015)

Nitric Oxide Prevents Alveolar Senescence and Emphysema in a Mouse Model
por: Boe, Amanda E., et al.
Publicado: (2015)

BH3 Peptides Induce Mitochondrial Fission and Cell Death Independent of BAX/BAK
por: Shroff, Emelyn H., et al.
Publicado: (2009)

Gene expression of lactobacilli in murine forestomach biofilms
por: Schwab, Clarissa, et al.
Publicado: (2014)

Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
por: Darwish, Ibrahim A, et al.
Publicado: (2011)

Hepatotoxicity Associated with a Short Course of Rosuvastatin
por: Hwang, Na Kyoung, et al.
Publicado: (2015)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
por: Heo, Ji Hoe, et al.
Publicado: (2016)

Examination of Physiologically‐Based Pharmacokinetic Models of Rosuvastatin
por: Bowman, Christine M., et al.
Publicado: (2020)

Exploring the molecular reorientations in amorphous rosuvastatin calcium
por: Belozerova, N. M., et al.
Publicado: (2020)

Rosuvastatin-Induced Rhabdomyolysis: A Case Report
por: Nikalji, Ravindra, et al.
Publicado: (2021)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dufdo7jsrbu2lqvsglelrt6j1q